FDA commissioner Dr. Scott Gottlieb expects that the shortage of IV fluids caused by Hurricane Maria in Puerto Rico will improve in the coming weeks and months, according to a statement issued by the agency yesterday. The regulatory chief said that the FDA is working with manufacturers like Baxter (NYSE:BAX) and B. Braun to import products […]
Baxter International
Illinois AG sues Baxter for polluting lake
Illinois attorney general Lisa Madigan hit Baxter Healthcare (NYSE:BAX) with a lawsuit yesterday, alleging that the company’s R&D facility dumped contaminated wastewater into a tributary that feeds into Long Lake, polluting the waters beyond allowable limits. Madigan filed the complaint in Lake County Circuit Court and urged the court to force Baxter to stop over-polluting the […]
Here’s what the FDA is doing about IV fluid shortages following hurricanes Maria, Irma
Nine weeks after hurricanes Maria and Irma brought devastation to Puerto Rico, FDA commissioner Dr. Scott Gottlieb says hospitals across the U.S. are reporting shortages of IV fluids – medical products that are often sourced from Puerto Rico. Hospitals are specifically noting that 0.9% injection bags of saline, used to inject drugs intravenously, are of […]
Baxter launches asset tracking system for infusion pumps
Baxter (NYSE:BAX) today launched the DeviceVue asset tracking solution for hospitals using its Sigma Spectrum infusion system. The product was designed to help clinicians and biomedical engineers quickly find unused pumps by viewing pump location and status data from their computers or phones. The company said it is the first and only smart infusion pump manufacturer to […]
Baxter closes $625m Claris Injectables buy
Baxter (NYSE:BAX) said today that it closed its $625 million acquisition of Claris Lifesciences‘ (BOM:533288) injectable drug biz. According to the deal, Baxter gains Claris’ portfolio of injectable generics and three manufacturing plants. The Deerfield, Ill.-based company said it plans to add new aseptic manufacturing and lyophilization capabilities, as well as invest in new technology platforms, […]
FTC approves Baxter’s $625m Claris buyout, with conditions
The Federal Trade Commission approved Baxter‘s (NYSE:BAX) $625 million acquisition of Claris Lifesciences‘ (BOM:533288) injectable drug biz, but mandated that the companies divest two drugs products – an antifungal agent, fluconazole, and intravenous milrinone. The FTC filed a complaint saying that the original deal would likely reduce competition in the U.S. for fluconazole since Baxter […]
Baxter integrates DoseEdge with Epic’s Willow pharmacy system
Baxter (NYSE:BAX) said today it will integrate its DoseEdge Pharmacy workflow manager with the Epic Willow Impatient Pharmacy system. The Deerfield, Ill.-based company said that the bi-directional integration between the dedicated intravenous workflow system and electronic medical records to help hospitals meet compliance requirements with the Centers for Medicare & Medicaid Services and other payors. “Every time […]
Baxter sees shares lift on Street-beating Q1 earnings release
Baxter (NYSE:BAX) shares have risen today after the medical device company topped expectations on Wall Street with its 1st quarter earnings results. The Deerfield, Ill.-based company posted profits of $272 million, or 50¢ per share, on sales of $2.48 billion for the 3 months ended March 31. The company saw its bottom line shrink 92% while […]
Hospira, Baxter subpoenaed in antitrust probe over intravenous saline
Drugmakers received grand jury subpoenas from the U.S. Justice Dept. this week in connection with an antitrust probe into companies that market intravenous saline solutions. ICU Medical (NSDQ:ICUI), which recently acquired Hospira Infusion Systems from Pfizer (NYSE:PFE), and Baxter (NYSE:BAX) disclosed the subpoenas this week. Pfizer revealed that it is also wrapped up in the investigation, according […]
Baxter reveals DoJ probe of Tisseel, Artiss sealants
Baxter (NYSE:BAX) this week said it received a civil investigative demand from the US Dept. of Justice’s Commercial Litigation Branch related to its Tisseel and Artiss products. The Deerfield, Ill.-based company said the inquiry relates to contingent discount arrangements and other promotions for the 2 sealant products, and that it was cooperating with the DoJ on […]
